Samsung Biologics signs manufacturing deal with European pharmaceutical company
Epigenic Therapeutics to Enter Clinical Development of EPI-003: A First-in-Class Epigenetic Inactivator for the Treatment of Chronic Hepatitis B
Warringtonfire Australia Rebrands to Jensen Hughes, Strengthening Global Fire Safety Engineering, Fire Testing and Fire Assessment Services
Moatable Reports Third Quarter 2024 Financial Results
Turpan's Wind Power Capacity Achieves New Milestone with Over 4 Billion kWh Generated in 2024
Richard Flanagan's Question 7 wins The Baillie Gifford Prize for Non-Fiction 2024
Richard Flanagan's Question 7 wins The Baillie Gifford Prize for Non-Fiction 2024
ZTO Reports Third Quarter 2024 Unaudited Financial Results


